aspirin has been researched along with 1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, M; Fujisaki, J; Motoyama, Y; Namikawa, Y; Sakata, Y; Seki, J; Takasugi, H; Tanaka, A; Yoshida, K | 1 |
1 other study(ies) available for aspirin and 1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine
| Article | Year |
|---|---|
The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor.
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Guinea Pigs; Humans; In Vitro Techniques; Irritants; Male; Malondialdehyde; Microsomes; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Rabbits; Rats; Rats, Sprague-Dawley; Seminal Vesicles; Sheep; Stomach Ulcer; Thiazoles | 1993 |